CSIMarket Company Name, Ticker, Industry, else..
 

Aethlon Medical Inc   (NASDAQ: AEMD)

Aethlon Medical Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

AEMD Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Aethlon Medical Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 21.86 %, recorded in the same quarter.

• List of AEMD Competitors





Revenue Growth Comparisons




Net Income Comparison

Aethlon Medical Inc recorded a net loss, as well as most of its competitors.

<<  AEMD Stock Performance Comparisons


Aethlon Medical Inc 's Comment on Competition and Industry Peers


The industry for treating infectious diseases and cancer is highly competitive and involves significant capital and regulatory challenges. The Hemopurifier, a clinical-stage device, must establish medical industry support through clinical study data. If cleared by the FDA or other regulatory bodies, the device may face competition from well-funded pharmaceutical organizations. Large-scale production would be necessary to remain competitive. A specific competitor identified is ExThera Medical Corporation, which produces blood filters.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Aethlon Medical Inc




Insight Molecular Diagnostics Inc
Share Performance



-7.49%
Over The Past 5 Days
Insight Molecular Diagnostics Inc
Profile

The company develops molecular diagnostic test kits for detecting transplanted organ rejection.

More about Insight Molecular Diagnostics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 145.163 mill. $ 1.670 mill. $ -49.359 mill.


Sigyn Therapeutics Inc
Share Performance



0.00%
30 Days
Sigyn Therapeutics Inc
Profile

Sigyn Therapeutics Inc has a business model focused on developing novel medical therapeutics for the treatment of life-threatening inflammatory conditions.

More about Sigyn Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ - mill. $ -3.221 mill.


Vericel Corporation
Share Performance



+1.04%
This Quarter
Vericel Corporation
Profile

Vericel Corporation's business model revolves around the development and commercialization of innovative cellular therapies for the treatment of severe diseases and conditions.

More about Vericel Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,038.599 mill. $ 306.303 mill. $ 24.221 mill.

Sources: Aethlon Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Aethlon Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.